Benjamin Golas
Overview
Explore the profile of Benjamin Golas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu A, Hanna D, Li T, Sarfaty E, Khajoueinejad N, Li J, et al.
Ann Surg Oncol
. 2024 Jul;
31(9):6252-6261.
PMID: 39003380
Background: The prognostic impact of genetic mutations for patients who undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) of colorectal origin (CRC) is not well defined. Objective: We aimed...
2.
Hanna D, Khajoueinejad N, Ghani M, Hermina A, Mina A, Bailey C, et al.
Am Surg
. 2024 Apr;
90(6):1577-1581.
PMID: 38587264
Background: While cholecystectomy is one of the most common operations performed in the United States, there is a continued debate regarding its prophylactic role in elective surgery. Particularly among patients...
3.
Khajoueinejad N, Sarfaty E, Yu A, Buseck A, Troob S, Imtiaz S, et al.
Ann Surg Oncol
. 2023 Dec;
31(4):2668-2678.
PMID: 38127214
Background: Frailty, a multidimensional state leading to reduced physiologic reserve, is associated with worse postoperative outcomes. Despite the availability of various frailty tools, surgeons often make subjective assessments of patients'...
4.
Macfie R, Berger Y, Liu H, Li T, Imtiaz S, Ang C, et al.
Ann Surg Oncol
. 2023 May;
30(8):5027-5034.
PMID: 37210446
Introduction: Guidelines for perioperative systemic therapy administration in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma (PDAC) and distal cholangiocarcinoma (dCCA) are evolving. Decisions regarding adjuvant therapy are influenced by postoperative morbidity,...
5.
Hanna D, Macfie R, Ghani M, Hermina A, Mina A, Cha D, et al.
J Surg Res
. 2022 Dec;
284:94-100.
PMID: 36563453
Introduction: Many patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for appendiceal adenocarcinoma peritoneal metastases (APM) undergo preoperative systemic chemotherapy. The primary aim of this study is to evaluate...
6.
Hanna D, Macfie R, Ghani M, Hermina A, Mina A, Cha D, et al.
J Surg Oncol
. 2022 Nov;
127(3):442-449.
PMID: 36350108
Background: The primary aim of this study is to evaluate the oncologic outcomes of two popular systemic chemotherapy approaches in patients with colorectal peritoneal metastases (CPM) undergoing cytoreductive surgery with...
7.
Pletcher E, Cha D, Gleeson E, Shaltiel T, Magge D, Sarpel U, et al.
Ann Surg Oncol
. 2022 Jul;
30(1):437-444.
PMID: 35907991
Background: Postoperative respiratory failure (PRF) is associated with increased morbidity after surgery. This retrospective study explores preoperative and perioperative risk factors associated with PRF in patients undergoing cytoreductive surgery and...
8.
Macfie R, Cha D, Gleeson E, Yu A, Cohen N, Sarpel U, et al.
J Surg Oncol
. 2022 Jun;
126(4):781-786.
PMID: 35668645
Introduction: Failure to rescue (FTR) is defined as death after a major complication. We evaluated FTR after cytoreductive surgery (CRS) with and without hyperthermic intraperitoneal chemotherapy (HIPEC). Methods: The ACS...
9.
Macfie R, Berger Y, Sarpel U, Hiotis S, Golas B, Labow D, et al.
Crit Rev Oncol Hematol
. 2022 Mar;
173:103654.
PMID: 35301097
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer, which commonly metastasizes to the liver. The current standard of care for metastatic PDAC is systemic chemotherapy, however there are limited emerging...
10.
Pletcher E, Gleeson E, Shaltiel T, Leigh N, Sullivan B, Labow D, et al.
Biomark Med
. 2021 Jul;
15(12):965-975.
PMID: 34289740
Lymphocyte-to-monocyte ratio (LMR) predicts overall survival (OS) in patients with colorectal cancer. We explored LMR in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). We identified all patients undergoing...